Wednesday, July 9, 2014
Contact: Monica Smith (301) 215-9099, ext. 201 email@example.com
Advocacy Network Announces Research Innovation Award Winner
BCAN Funding Reaches $1 Million
BETHESDA, MD – TheAdvocacy Network (BCAN) is pleased to recognize William Kim, MD, Associate Professor of Medicine, Urology, and Genetics, University of North Carolina at Chapel Hill and UNC Lineberger Comprehensive Cancer Center with the 2014 Research Innovation Award to support his project “Immune Characterization of High- .” The $300,000 two-year grant is generously supported by the James Family Foundation, in conjunction with Partner Fund Management. The aim of the 2014 Research Innovation Award is to support an exceptionally novel and creative project with great potential to produce breakthroughs in the management of .
Dr. Kim is a seasoned researcher at UNC Chapel Hill who hopes to bring genetic discoveries to. He has received numerous accolades and honors including a 2002 ASCO Young Investigator Award and 2009 Damon Runyon Clinical Investigator Award. Dr. Kim is also a National Cancer Institute funded researcher.
Dr. Kim will investigate the role ofin combating . treatments have been responsible for long-lasting responses in other types of cancer. With this research project, Dr. Kim hopes to both characterize the immune infiltrate found in bladder tumors as well as determine whether the recently described basal-like molecular subtype of can serve as a predictive biomarker for response and provide guidance on optimal therapy combinations, ultimately improving treatment options for those living with .
With this $300,000 award, theAdvocacy Network has invested $1 million to fund research since 2010. is the 6th most commonly diagnosed cancer in the United States and one of the most expensive cancers to treat, yet research is woefully underfunded.
“This is a significant milestone for BCAN to reach in a short period of time. We are overwhelmed by the success of the research program. We received 74 letters of intent for theInnovation Award but could choose only one project,” stated Diane Zipursky Quale, President and Co-Founder. “The interest in research is strong and we need to continue to raise funds to support programs that will yield discoveries.”
TheResearch Innovation Award complements the organization’s Young Investigator Awards, initiated in 2013, which engages young scientists. Three grants were awarded in 2014 totaling $300,000.
2014 BCAN YOUNG INVESTIGATOR AWARD Sunny Guin, PhD, Postdoctoral Fellow, University of Colorado at Denver “The Role, Relationship and Therapeutic Potential of HAS2 and AGL in.”
2014 JPB FOUNDATION YOUNG INVESTIGATOR AWARD Ryoichi Saito, MD, PhD, Research Associate, University of North Carolina at Chapel Hill “Consequences of ARID1A Inactivation in.”
2014 JPB FOUNDATION YOUNG INVESTIGATOR AWARD Dmitriy Zamarin, MD, PhD Hematology/Oncology Fellow, Memorial Sloan-Kettering Cancer Center “DefiningTargets in Microenvironment Using Oncolytic Viruses.”
For more information, go to www.bcan.org or contact BCAN at 301-215-9099.
About the Advocacy Network
TheAdvocacy Network’s (BCAN) mission is to increase public awareness about , advance research, and provide educational and support services for the community.
BCAN serves as the leading voice forin the U.S., providing resources to not only those diagnosed with the disease but their families, caregivers and the medical community united in support of people touched by the disease. The organization is setting the agenda for by promoting and funding collaborative and cutting-edge research programs and providing critical patient support and education services. Each year, it provides thousands of patients, caregivers and the medical community with the educational resources and support services they need to navigate their journey. BCAN works collaboratively with the medical and research professionals who are dedicated to the prevention, diagnosis and treatment of and empowers the patient community by allowing them to share experiences with others, and to participate in building awareness of the need for a cure.